Blood Clotting also known as coagulation is the bodys response to an injury to prevent bleeding. It prevents excessive bleeding when the blood vessels are injured. However, a clot can be harmful when it forms abnormal flows through the vessels. The excessive formation of clots in the blood leads to different diseases such as brain stroke, heart attack and severe leg pain. Blood Clot forms in one or more veins located deep inside a human body would lead to Deep Vein Thrombosis (DVT) and could damage an organ completely.
Clot Management Devices Market contains market size and forecasts of Clot Management Devices in global, including the following market information:
- Global Clot Management Devices Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global Clot Management Devices Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Clot Management Devices companies in 2021 (%)
The global Clot Management Devices market was valued at 1303.3 million in 2021 and is projected to reach US$ 1662.7 million by 2028, at a CAGR of 3.5% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Neurovascular Embolectomy Devices Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Clot Management Devices include Teleflex, Edwards Lifesciences, Medtronic, Boston Scientific, Lemaitre Vascular, Straub Medical, Cook Medical and Johnson & Johnson, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Clot Management Devices manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Clot Management Devices Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Clot Management Devices Market Segment Percentages, by Type, 2021 (%)
- Neurovascular Embolectomy Devices
- Embolectomy Balloon Catheters
- Percutaneous Thrombectomy Devices
- Catheter-Directed Thrombolysis Devices
- Inferior Vena Cava Filters (IVCF)
Global Clot Management Devices Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Clot Management Devices Market Segment Percentages, by Application, 2021 (%)
- Hospitals
- Diagnostic Centres
- Others
Global Clot Management Devices Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Clot Management Devices Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Clot Management Devices revenues in global market, 2017-2022 (Estimated), ($ millions)
- Key companies Clot Management Devices revenues share in global market, 2021 (%)
- Key companies Clot Management Devices sales in global market, 2017-2022 (Estimated), (K Units)
- Key companies Clot Management Devices sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Teleflex
- Edwards Lifesciences
- Medtronic
- Boston Scientific
- Lemaitre Vascular
- Straub Medical
- Cook Medical
- Johnson & Johnson
Industry Market Size
